La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1-Deoxynojirimycin (therapeutic use) < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (administration & dosage)  Facettes :

List of bibliographic references indexed by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
000221 (2016) Mohammed Filali [Canada] ; Robert Lalonde [France]Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.
000240 (2016) Lucie Hopes [France] ; Guillaume Grolez [France] ; Caroline Moreau [France] ; Renaud Lopes [France] ; Gilles Ryckewaert [France] ; Nicolas Carrière [France] ; Florent Auger [France] ; Charlotte Laloux [France] ; Maud Petrault [France] ; Jean-Christophe Devedjian [France] ; Regis Bordet [France] ; Luc Defebvre [France] ; Patrice Jissendi [France] ; Christine Delmaire [France] ; David Devos [France]Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
000993 (2014) Wai Kin D. Ko [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [République populaire de Chine]Effects of L-tryptophan on L-DOPA-induced dyskinesia in the L-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease.
001954 (2010) Léon Tremblay [France][Pathophysiology of Parkinson's disease: an update].
001A45 (2010) Pierre-Olivier Fernagut [France] ; Qin Li [Royaume-Uni, République populaire de Chine] ; Sandra Dovero [France] ; Piu Chan [République populaire de Chine] ; Tao Wu [République populaire de Chine] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Zhenwen Chen [République populaire de Chine] ; Erwan Bezard [France, République populaire de Chine]Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
001C61 (2010) Léon Tremblay [France]Où en sommes-nous sur la physiopathologie de la maladie de Parkinson ?
001D12 (2010) Julie Deguil [France] ; François Chavant [France] ; Claire Lafay-Chebassier [France] ; Marie-Christine Perault-Pochat [France] ; Bernard Fauconneau [France] ; Stéphanie Pain [France]Time course of MPTP toxicity on translational control protein expression in mice brain
001E90 (2009) Sarah Vautier [France] ; Aline Milane ; Christine Fernandez ; Helene Chacun ; Lucette Lacomblez ; Robert FarinottiRole of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
002D42 (2005) Wassilios Meissner [France, Allemagne] ; Arthur Leblois [France] ; David Hansel [France] ; Bernard Bioulac [France] ; Christian E. Gross [France] ; Abdelhamid Benazzouz [France] ; Thomas Boraud [France]Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations
003067 (2003) Caroline Prunier [France] ; Erwan Bézard ; Jérôme Montharu ; Marina Mantzarides ; Jean-Claude Besnard ; Jean-Louis Baulieu ; Christian Gross ; Denis Guilloteau ; Sylvie ChalonPresymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT.
003089 (2003) E C Hirsch [France] ; G. Höglinger ; E. Rousselet ; T. Breidert ; K. Parain ; J. Feger ; M. Ruberg ; A. Prigent ; C. Cohen-Salmon ; J M LaunayAnimal models of Parkinson's disease in rodents induced by toxins: an update.
003968 (2000) Imad Ghorayeb [France] ; Pierre O. Fernagut [France] ; Incarnation Aubert [France] ; Erwan Bezard [France] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] ; François Tison [France]Toward a primate model of l‐dopa‐unresponsive parkinsonism mimicking striatonigral degeneration
003A44 (2000) Th Boraud [France] ; E. Bezard [France] ; J. M Stutzmann [France] ; B. Bioulac [France] ; C. E Gross [France]Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey
003A51 (2000) Caroline Jan [France] ; Chantal François [France] ; Dominique Tandé [France] ; Jérôme Yelnik [France] ; Léon Tremblay [France] ; Yves Agid [France] ; Etienne Hirsch [France]Dopaminergic innervation of the pallidum in the normal state, in MPTP‐treated monkeys and in parkinsonian patients
003B57 (2000) A. Boireau [France] ; P. Dubedat [France] ; F. Bordier [France] ; A. Imperato [France] ; S. Moussaoui [France]The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation
003C51 (1999) E. Bezard [France] ; T. Boraud ; B. Bioulac ; C E GrossInvolvement of the subthalamic nucleus in glutamatergic compensatory mechanisms.
004028 (1998) Joao Villares [France] ; Baptiste Faucheux [France] ; Maria T. Herrero [Espagne] ; Jose A. Obeso [Espagne] ; Charles Duyckaerts [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France][125I]EGF Binding in Basal Ganglia of Patients with Parkinson's Disease and Progressive Supranuclear Palsy and in MPTP-Treated Monkeys
004412 (1997) A. Boireau [France] ; F. Bordier [France] ; P. Dubedat [France] ; C. Peny [France] ; A. Imperato [France]Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice
004459 (1997) E. Bezard [France] ; C. Imbert [France] ; X. Deloire [France] ; B. Bioulac [France] ; C. E. Gross [France]A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey
004478 (1996) P. Hantraye [France] ; E. Brouillet ; R. Ferrante ; S. Palfi ; R. Dolan ; R T Matthews ; M F BealInhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.
004581 (1996) P. Barnéoud [France] ; M. Mazadier [France] ; J.-M. Miquet [France] ; S. Parmentier [France] ; P. Dubédat [France] ; A. Doble [France] ; A. Boireau [France]Neuroprotective effects of riluzole on a model of parkinson's disease in the rat

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024